Source: Medical Buyer

PQ Bypass: PQ Bypass gets FDA breakthrough device status for Detour system

Medical device company PQ Bypass has secured breakthrough device designation from the US Food and Drug Administration (FDA) for its fully-percutaneous femoral-popliteal bypass device called Detour System. The Detour System...Read More

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Richard Ferrari's photo - Chairman & CEO of PQ Bypass

Chairman & CEO

Richard Ferrari

CEO Approval Rating

78/100

Read more